Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report
No Thumbnail Available
Date
2012-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Description
Bu çalışma, 28 Eylül-02 Ekim 2012 tarihleri arasında Vienna[Austria]’da düzenlenen 37. Congress of the European-Society-for-Medical-Oncology (ESMO)’da bildiri olarak sunulmuştur.
Keywords
Oncology
Citation
Avcı, N. vd. (2012). "Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report". Annals of Oncology, 23, Supplement 9, 129-129.